These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19610267)

  • 21. [A case of interstitial pneumonitis caused by intravesical bacillus Calmette-Guérin instillation].
    Horinaga M; Nakamura K; Nishiyama T; Murai M
    Hinyokika Kiyo; 1999 Jul; 45(7):493-5. PubMed ID: 10466068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
    Shimasaki N; Yamasaki I; Kamada M; Syuin T
    Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
    Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F
    Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665
    [No Abstract]   [Full Text] [Related]  

  • 24. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
    Aust TR; Massey JA
    Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma.
    Uppal GS; Shah AN; Tossounis CM; Tappin MJ
    Ocul Immunol Inflamm; 2010 Aug; 18(4):292-6. PubMed ID: 20662661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterium bovis vertebral osteomyelitis and discitis with adjacent mycotic abdominal aortic aneurysm caused by intravesical BCG therapy: a case report in an elderly gentleman.
    Samadian S; Phillips FM; Deeab D
    Age Ageing; 2013 Jan; 42(1):129-31. PubMed ID: 23151379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids.
    Molina JM; Rabian C; D'Agay MF; Modai J
    J Urol; 1992 Mar; 147(3):695-7. PubMed ID: 1538462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravesical immunotherapy on sperm parameters in young patients with non--muscle-invasive bladder carcinoma: prospective analysis.
    Garg M; Sankhwar SN; Goel A; Kumar M; Singh BP; Singh V; Dalela D; Kumar A; Paul S
    Clin Genitourin Cancer; 2014 Jun; 12(3):e83-6. PubMed ID: 24411194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T helper cell alveolitis after bacillus Calmette-Guerin immunotherapy for superficial bladder tumor.
    Reinert KU; Sybrecht GW
    J Urol; 1994 Jun; 151(6):1634-7. PubMed ID: 8189583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.
    Thalmann GN; Sermier A; Rentsch C; Möhrle K; Cecchini MG; Studer UE
    J Urol; 2000 Dec; 164(6):2129-33. PubMed ID: 11061941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical Bacillus Calmette-Guérin treatment for superficial bladder cancer: results after 15 years of experience.
    van der Meijden AP; Steerenberg PA; de Jong WH; Debruyne FM
    Anticancer Res; 1991; 11(3):1253-8. PubMed ID: 1888156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated Bacillus Calmette-Guerin infections after intravesical therapy.
    Gerogianni I; Gravas S; Gourgoulianis K; Neonakis I; Petinaki E
    Indian J Med Microbiol; 2014; 32(4):438-9. PubMed ID: 25297033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
    Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
    Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiorgan failure following intravesical bacillus Calmette-Guerin administration: a case report].
    Baba Y; Ishizu K; Jojima K; Joko K; Nakamura K; Takihara H; Naito K
    Hinyokika Kiyo; 1992 Sep; 38(9):1063-5. PubMed ID: 1414761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
    Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
    Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].
    Shiba M; Fujii T; Takatera H
    Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
    Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of previous bacille Calmette-Guérin failure pattern on subsequent response to bacille Calmette-Guérin plus interferon intravesical therapy.
    Gallagher BL; Joudi FN; Maymí JL; O'Donnell MA
    Urology; 2008 Feb; 71(2):297-301. PubMed ID: 18308107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma.
    Böhle A; Rüsch-Gerdes S; Ulmer AJ; Braasch H; Jocham D
    J Urol; 1996 Jun; 155(6):1892-6. PubMed ID: 8618281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.